始于1953年,專注于化學制藥/維生素及營養保健品/現代中藥/生物農獸藥等領域,集研發/生產/服務于一體的現代化醫藥健康產業集團
華北制(zhi)(zhi)藥(yao)(yao)集團有限責任(ren)公(gong)(gong)司(si)(簡稱(cheng):華藥(yao)(yao)集團)位于河北省省會石家莊市(shi)。前身(shen)華北制(zhi)(zhi)藥(yao)(yao)廠(chang)是中(zhong)國(guo)“一五”計劃期間的(de)重(zhong)點建(jian)(jian)設項(xiang)目,1953年(nian)(nian)6月開始(shi)籌建(jian)(jian),1958年(nian)(nian)6月建(jian)(jian)成投產,開創(chuang)了(le)我國(guo)大(da)規模生(sheng)產抗生(sheng)素的(de)歷(li)史,為(wei)人(ren)類健康事業、民族制(zhi)(zhi)藥(yao)(yao)工業發展和改(gai)變我國(guo)缺醫少藥(yao)(yao)局面做出了(le)重(zhong)要貢獻。1992年(nian)(nian)重(zhong)組(zu)設立華北制(zhi)(zhi)藥(yao)(yao)股份有限公(gong)(gong)司(si),1994年(nian)(nian)在上(shang)交(jiao)所掛牌(pai)上(shang)市(shi)(股票名稱(cheng):華北制(zhi)(zhi)藥(yao)(yao)600812)。1996年(nian)(nian)1月,華北制(zhi)(zhi)藥(yao)(yao)廠(chang)正式改(gai)制(zhi)(zhi)為(wei)國(guo)有獨資公(gong)(gong)司(si)——華北制(zhi)(zhi)藥(yao)(yao)集團有限責任(ren)公(gong)(gong)司(si)。2009年(nian)(nian)6月,經河北省政府批(pi)準,冀(ji)中(zhong)能源(yuan)集團對華藥(yao)(yao)集團實(shi)施(shi)了(le)重(zhong)組(zu)。
多(duo)年來,華藥(yao)(yao)集(ji)團(tuan)秉(bing)承“人(ren)類(lei)健(jian)康(kang)至上(shang),質量永遠第(di)一”的企業(ye)宗旨,持(chi)續創新,穩健(jian)經(jing)(jing)營(ying),逐步壯大,經(jing)(jing)營(ying)范圍(wei)不斷(duan)拓展,發展業(ye)績保(bao)持(chi)優(you)良,主(zhu)要經(jing)(jing)濟技(ji)術(shu)(shu)指(zhi)標始終處(chu)于國(guo)內同行業(ye)前(qian)列。截(jie)至2018年底,華藥(yao)(yao)集(ji)團(tuan)資產(chan)總額(e)206億元(yuan),職工(gong)近(jin)1.5萬人(ren),擁有四(si)十多(duo)家(jia)子(zi)(分(fen))公司,擁有微生(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)藥(yao)(yao)物(wu)(wu)(wu)國(guo)家(jia)工(gong)程研究(jiu)中心、抗(kang)(kang)(kang)(kang)體藥(yao)(yao)物(wu)(wu)(wu)研制國(guo)家(jia)重點實驗(yan)室(shi)、抗(kang)(kang)(kang)(kang)生(sheng)(sheng)(sheng)(sheng)(sheng)素(su)酶催(cui)化與結晶技(ji)術(shu)(shu)國(guo)家(jia)地(di)方(fang)聯(lian)合(he)工(gong)程實驗(yan)室(shi)三個創新平臺(tai),主(zhu)要產(chan)品涉及化學制藥(yao)(yao)、現(xian)(xian)代(dai)(dai)生(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)技(ji)術(shu)(shu)藥(yao)(yao)物(wu)(wu)(wu)、維生(sheng)(sheng)(sheng)(sheng)(sheng)素(su)及營(ying)養保(bao)健(jian)品、現(xian)(xian)代(dai)(dai)中藥(yao)(yao)、生(sheng)(sheng)(sheng)(sheng)(sheng)物(wu)(wu)(wu)農獸藥(yao)(yao)等領域近(jin)千個品規,治療(liao)領域涵蓋抗(kang)(kang)(kang)(kang)感染類(lei)、心腦血管類(lei)、腎病(bing)、抗(kang)(kang)(kang)(kang)腫瘤及免疫調節類(lei)等,主(zhu)要生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)單元(yuan)的工(gong)藝路(lu)線、生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)布局全(quan)部按照(zhao)歐美現(xian)(xian)行版(ban)、中國(guo)新版(ban)GMP標準設(she)計實施(shi),擁有具備國(guo)際領先(xian)水準的現(xian)(xian)代(dai)(dai)化制藥(yao)(yao)生(sheng)(sheng)(sheng)(sheng)(sheng)產(chan)平臺(tai)。